Form 4: MPW Senior VP Acquires 84,801 Shares
Insider Transaction Report
Medical Properties Trust Senior VP, Controller & CAO, James Kevin Hanna, acquired 84,801 shares of common stock through equity grants, aligning executive interests with shareholder value.
Summary
- James Kevin Hanna, Senior VP, Controller & CAO of Medical Properties Trust Inc (MPW), acquired a total of 84,801 shares of common stock.
- The transactions occurred on September 24, 2025, with a reported price of $0.00 per share, indicating these were equity grants.
- Following these transactions, Mr. Hanna beneficially owns 449,231 shares of MPW common stock.
- A grant of 59,743 shares will vest quarterly, concluding on March 31, 2028.
- An additional grant of 25,058 shares is performance-based, tied to the company's Total Shareholder Return (TSR) over a three-year period ending April 14, 2028.
- Performance hurdles for the 25,058 shares are 20% TSR for 100% earning, 40% TSR for 200% earning, and 60% TSR for 300% earning, with linear interpolation for intermediate performance.
- Earned performance shares will vest in equal quarterly installments over one year, or fully upon the Compensation Committee's final determination, subject to continued employment.
Sentiment
Score: 7
Explanation: The filing reports routine executive equity grants, including performance-based awards, which generally align management interests with shareholder value and incentivize long-term performance.
Positives
- The acquisition of shares by a senior executive, James Kevin Hanna, through equity grants, aligns management's financial interests with those of shareholders.
- Performance-based vesting for 25,058 shares incentivizes the executive to achieve significant Total Shareholder Return (TSR) targets (20%, 40%, 60% TSR).
- The vesting schedules encourage long-term commitment and retention of key management personnel.
Risks
- The performance-based shares (25,058 shares) are subject to the achievement of specific Total Shareholder Return (TSR) hurdles, meaning the executive may not earn the full potential grant if performance targets are not met.
- The vesting of all granted shares is contingent on the grantee's continued employment through the respective vesting dates.
Future Outlook
The company has established performance-based equity incentives tied to Total Shareholder Return (TSR) targets for a senior executive, with a performance period extending to April 14, 2028. This indicates a focus on long-term shareholder value creation and executive retention through structured vesting schedules.
Industry Context
Equity grants, particularly those with performance-based vesting components like Total Shareholder Return (TSR) hurdles, are a common practice in the real estate investment trust (REIT) sector and broader corporate landscape. They are designed to align executive incentives with long-term shareholder value creation and are a standard component of executive compensation packages aimed at attracting and retaining top talent.
Comparison to Industry Standards
- The use of equity grants with a $0.00 acquisition price is standard for restricted stock units (RSUs) or performance share units (PSUs) as part of executive compensation.
- TSR hurdles (20%, 40%, 60%) for performance-based awards are within the typical range seen in similar industries, aiming to incentivize above-average market performance. For example, many S&P 500 companies utilize relative or absolute TSR targets for their long-term incentive plans.
- The multi-year vesting schedules (e.g., quarterly vesting until March 2028, or one year post-earning for performance shares) are consistent with industry best practices for executive retention and long-term alignment, comparable to structures at companies like Prologis (PLD) or Simon Property Group (SPG) for their executive equity awards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | The shares were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan, demonstrating the ongoing use of the plan for executive compensation. | 09/24/2025 | Reinforces the company's established framework for executive compensation and alignment with shareholder interests. |
Related Party Transactions
- The equity grants to James Kevin Hanna, a Senior VP, Controller & CAO, represent a form of compensation to a related party (executive management).
Stakeholder Impact
- Shareholders: Potential positive impact through increased alignment of executive interests with shareholder value, especially via performance-based awards tied to TSR.
- Employees: The equity incentive plan provides a framework for executive compensation, which can influence overall compensation philosophy within the company.
Next Steps
- Continued vesting of 59,743 shares on a quarterly basis until March 31, 2028.
- Evaluation of the company's Total Shareholder Return (TSR) performance over the three-year period ending April 14, 2028, to determine the number of earned performance-based shares.
- Subsequent quarterly vesting of earned performance shares over one year, or full vesting upon Compensation Committee determination.
Key Dates
| Date | Description |
|---|---|
| 09/24/2025 | Date of non-derivative securities acquisition by James Kevin Hanna. |
| 09/26/2025 | Signature date of the reporting person's power of attorney. |
| 03/31/2028 | End date for quarterly vesting of 59,743 shares. |
| 04/14/2028 | End of the three-year performance period for the 25,058 performance-based shares. |
Keywords
Medical Properties Trust, MPW, Insider Trading, Form 4, Equity Grant, Executive Compensation, Stock Award, TSR, Performance Shares, Vesting, James Kevin Hanna
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.